Submit a Proposal
Apply Online available soon
Fast Forward Funding
With leadership funding from EMD Serono, Inc, Fast Forward has released a new Request for Proposal (PDF) focused on the development of novel therapeutic approaches to prevent, treat or reverse central nervous system damage in multiple sclerosis.
RFP Priorities
- Modulation of innate and/or adaptive immunity to promote CNS neuroprotection and/or repair
- Molecular strategies for direct CNS neuroprotection
- Molecular approaches for CNS repair and remyelination
- Regenerative cell therapies and related platform technologies
Proposals responsive to the RFP should be focused on:
- Novel therapies with or close to proof of in vivo activity
- Innovative new molecular mechanisms with a defined plan to reach a value adding milestone within 1-2 years
Funding
- Up to $250,000 (direct and indirect costs) in funding is available for one year for university-based investigators and seed-stage for-profit commercial organizations applying for the Accelerating Innovation Fund.
- Up to $500,000 (direct and indirect costs) in funding is available for one year to for-profit commercial organizations applying for the Accelerating Commercial Development Fund.
Important Dates/Deadlines
June 1, 2009 – Informational teleconference
July 1, 2009 – Informational teleconference (Repeat)
July 28, 2009 – Deadline for preliminary proposals
October 28, 2009 – Deadline for invited full proposals
December, 2009 – Awards made
Click here to view the funding process
Contact Us
research@fastforward.org